Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Sunbaked biotechnology in Australia

Nature Biotechnology volume 20, pages 873–877 (2002)Cite this article

The combination of a strong science base, and encouraging and supportive private and public sectors, has recently warmed Australia's biotech sector back to life.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The movement of various indices (1997–2002) revealing the growth in strength in the Australian biotechnology industry.

© Bob Crimi

Figure 2: Australian and New Zealand venture capital investments in healthcare and bioscience from 1996–97 to 2000–01.

© Bob Crimi

References

  1. Freehills & Ernst & Young. Australian biotechnology report (ISR Corporate Communications, Canberra, Australia, 2001).

  2. Aoris Nova & Advance Consulting & Evaluation. Australian bioindustry review (Sydney, 2001).

  3. Deloitte Touche Tohmatsu. 7th Deloitte Biotech Index: a review of key biotechnology stocks listed on the Australian Stock Exchange (Sydney, 2001).

  4. Pollitecon Publications & Advance Consulting & Evaluation. The venture capital and the healthcare/bioscience sector in Australia and New Zealand report (Sydney, 2002).

  5. Ernst & Young & Hay Group Strategic Industry Research Foundation. Benchmarking study of R&D costs in selected segments of Australian biotechnology (Canberra, 2001).

  6. IMD. IMD World Competitiveness Yearbook (Lausanne, Switzerland, 2001).

  7. Norrie, C. Australian states compete for biotech primacy. Nat. Biotechnol. 20, 760, 2002.

    Article  CAS  Google Scholar 

  8. Dwyer, T. The Menzies Centre for Population Health Research. Medical Journal of Australia. 175, 617–620 (2002)

  9. AusBiotech Limited. Growing Australian biotechnology through access to people and capital (Melbourne, 2001).

  10. Hill, J., Kirchner, A., and Holmes, A. Federal Department of Industry, Science, and Resources. Pharmaceutical industry action agenda discussion paper (Canberra, 2001).

Download references

Author information

Authors and Affiliations

  1. managing director of the bioinformatics company BioLateral) and a freelance writer and educator specializing in bioinformatics, Sydney, New South Wales, Australia

    Tim Littlejohn

Authors
  1. Tim Littlejohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Littlejohn, T. Sunbaked biotechnology in Australia. Nat Biotechnol 20, 873–877 (2002). https://doi.org/10.1038/nbt0902-873

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0902-873

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing